Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,360.70
-9.50 (-0.69%)
At close: Mar 6, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 188.49 billion as of March 6, 2026. Its market cap has increased by 9.44% in one year.
Market Cap
188.49B
Enterprise Value
215.75B
Revenue
30.65B
Ranking
n/a
PE Ratio
43.02
Stock Price
1,360.70
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 188.49B, an increase of 127.90%. That is a compound annual growth rate of 9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 188.49B | -8.09% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 380.78B |
| Ajanta Pharma | 371.53B |
| Gland Pharma | 281.14B |
| Emcure Pharmaceuticals | 275.55B |
| Wockhardt | 212.08B |
| Piramal Pharma | 203.56B |
| NATCO Pharma | 179.25B |
| Alembic Pharmaceuticals | 139.07B |